PDL BioPharma, Inc. (
) has announced an ex-dividend date of December 05, 2012 and a cash
dividend payment of $0.15 per share scheduled for December 14,
2012. Shareholders who purchased PDLI stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
marks the 8th quarter that PDLI has paid the same dividend. At the
current stock price of $7.9, the dividend yield is 7.59%.
The previous trading day's last sale of PDLI was $7.9,
representing a -6.29% decrease from the 52 week high of $8.43 and a
37.15% increase over the 52 week low of $5.76.
PDLI is a part of the Health Care sector, which includes
companies such as Amgen Inc. (
) and Gilead Sciences, Inc. (
). PDLI's current earnings per share, an indicator of a company's
profitability, is $1.37. Zacks Investment Research reports PDLI's
forecasted earnings growth in 2012 as 20.51%, compared to an
industry average of 8.5%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to PDLI through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:
- WisdomTree SmallCap Earnings Fund (
The top-performing ETF of this group is EES with an increase of
2.11% over the last 100 days. It also has the highest percent
weighting of PDLI at 0.61%.